Warning:  Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525 
 
Deprecated:  str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525 
  
 
Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530 
 
Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531 
   English Wikipedia
  Nephropedia Template TP (
  Twit Text
 
  DeepDyve Pubget Overpricing |    
 
  lüll WT1 (Wilms  tumor gene 1): biology and cancer immunotherapy Sugiyama HJpn J Clin Oncol  2010[May]; 40 (5): 377-87Wilms' tumor gene WT1 encodes a transcription factor and plays an important role  in cell growth and differentiation. The WT1 gene is highly expressed in leukemia  and various types of solid tumors, whereas WT1 is a tumor marker convenient for  the detection of minimal residual disease of leukemia. The WT1 gene was  originally defined as a tumor suppressor gene, but we proposed that it was, on  the contrary, an oncogene. Furthermore, the WT1 protein has proven to be a  promising tumor-associated antigen, in which many human leukocyte antigen class  I- or II-restricted WT1 epitopes have been identified. Clinical trials of  WT1-targeted immunotherapy have confirmed its safety and clinical efficacy.  WT1-specific cytotoxic T lymphocytes and WT1 antibodies are spontaneously induced  in tumor-bearing patients, probably because of high immunogenicity of the WT1  protein. WT1-specific cytotoxic T lymphocytes make a major contribution to the  graft-versus-leukemia effect after allogenic stem cell transplantation. When 75  cancer antigens including WT1 were prioritized according to several criteria such  as therapeutic function and immunogenicity, WT1 was ranked as the top antigen.  These findings suggest that a new era of WT1 immunotherapy is imminent.|*Biomarkers, Tumor[MESH]|*Cancer Vaccines[MESH]|*Genes, Wilms Tumor[MESH]|Humans[MESH]|Leukemia/genetics/therapy[MESH]|Neoplasms/*genetics/physiopathology/*therapy[MESH]|WT1 Proteins/*immunology[MESH] |